Evidence map›Paper›PMID 38912839›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

Reappraising the Role of T Cell-Derived IFN-γ in Restriction of Mycobacterium tuberculosis in the Murine Lung.

Karolina Maciag, Courtney R Plumlee, Sara B Cohen, Benjamin H Gern, Kevin B Urdahl

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. HowVaccines · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Karolina MaciagDivision of Allergy and Infectious Diseases, University of Washington, Seattle, WA.ORCID 0000-0003-0803-4312
Courtney R PlumleeSeattle Children's Research Institute, Seattle, WA.ORCID 0000-0001-7142-4394
Sara B CohenSeattle Children's Research Institute, Seattle, WA.ORCID 0000-0002-7850-3498
Benjamin H GernSeattle Children's Research Institute, Seattle, WA.ORCID 0000-0002-0142-5970
Kevin B UrdahlSeattle Children's Research Institute, Seattle, WA.ORCID 0000-0003-0088-1066

Funding

IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) - SARS-CoV-2 RELATED RESEARCH75N93019C00070 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI URDAHL, KEVIN · 2019 to 2025
$86.6M
Technology CoreU19AI135976 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADEREM, ALAN A · 2018 to 2022
$17.0M
HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
Systems Biology, Bioinformatics, & Data IntegrationU19AI162583 · NIAID · UNIVERSITY OF WASHINGTON · PI COX, JEFFERY S, HAWN, THOMAS R · 2021 to 2025
$13.0M
Seattle Tuberculosis Research Advancement CenterP30AI168034 · NIAID · UNIVERSITY OF WASHINGTON · PI CHETAN SESHADRI · 2022 to 2026
$6.3M
Dissecting the molecular regulation of T cell localization and function within the Mycobacterium tuberculosis granulomaK08AI166072 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI Benjamin Henry Gern · 2022 to 2026
$929k
American Lung Association (ALA) CAALA2023Firland Foundation (The Firland) 20230026CHHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) 5K08AI166072HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U19AI135976NIAID NIH HHS 75N93019C00070NIAID NIH HHS K08 AI166072NIAID NIH HHS P30 AI168034NIAID NIH HHS T32 AI007044NIAID NIH HHS U19 AI135976NIAID NIH HHS U19 AI162583Seattle TB Research Advancement Center (SEATRAC) 1P30AI168034-01
6 · The paper itself

Abstract

T cells producing IFN-γ have long been considered a stalwart for immune protection against Mycobacterium tuberculosis (Mtb), but their relative importance to pulmonary immunity has been challenged by murine studies that achieved protection by adoptively transferred Mtb-specific IFN-γ-/- T cells. Using IFN-γ-/- T cell chimeric mice and adoptive transfer of IFN-γ-/- T cells into TCRβ-/-δ-/- mice, we demonstrate that control of lung Mtb burden is in fact dependent on T cell-derived IFN-γ, and, furthermore, mice selectively deficient in T cell-derived IFN-γ develop exacerbated disease compared with T cell-deficient control animals, despite equivalent lung bacterial burdens. Deficiency in T cell-derived IFN-γ skews infected and bystander monocyte-derived macrophages to an alternative M2 phenotype and promotes neutrophil and eosinophil influx. Our studies support an important role for T cell-derived IFN-γ in pulmonary immunity against tuberculosis.

Indexed as

Interferon-gammaLungMice, KnockoutMycobacterium tuberculosisTuberculosis, PulmonaryAdoptive TransferAnimalsMacrophagesMiceMice, Inbred C57BLNeutrophilsT-LymphocytesIFNG protein, mouseInterferon-gamma

Identifiers

PMID38912839
PMCPMC11249196

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.